Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

23 Dec 2020

Abstract excerpt

To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA) and one self-amplifying RNA (saRNA) vaccines, all currently under clinical development, as well as for a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33374802
DOI: 10.3390/vaccines9010003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic DemandPMID 33374802Read ↗

Accelerating manufacturing to enable large-scale supply of a new adenovirus-vectored vaccine within 100 daysSemantic proximity Read ↗

From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity Read ↗

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19Semantic proximity Read ↗

Emerging Technologies for Low‐Cost, Rapid Vaccine ManufactureSemantic proximity Read ↗

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19Semantic proximity Read ↗

Bioprocess Engineering Issues That Would Be Faced in Producing a DNA Vaccine at up to 100 m<sup>3</sup> Fermentation Scale for an Influenza PandemicSemantic proximity Read ↗

Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3)Semantic proximity Read ↗

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?Semantic proximity Read ↗

Advances in the design and delivery of RNA vaccines for infectious diseasesSemantic proximity Read ↗

Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity Read ↗

From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process developmentSemantic proximity Read ↗

Status and future developments for downstream processing of biological products Perspectives from the Recovery XIX yield roundtable discussionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.